Combination Immunotherapy with Galectin-3 Inhibitor GR-MD-02 Enhances Effects in Pre-clinical Models and Early …EconoTimesNORCROSS, Ga., Feb. 07, 2017 — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target gale… Continue reading
India to frame policy on synthetic biologyThe Hindu… : India is taking its first steps to evolve a policy on synthetic biology, an emerging science through which new life forms can potentially be made in labs and existing life forms, such as bacteria… Continue reading
OncLive |
Dr. Socinski on Recent Setbacks in Immunotherapy Combinations in NSCLC
OncLive Mark A. Socinski, MD, executive medical director of the Florida Hospital Cancer Institute, discusses recent setbacks in immunotherapy combinations in non–small cell lung cancer (NSCLC). In January 2017, both Bristol-Myers Squibb (BMS) an AstraZeneca … |
|
CRISPR Trials To Watch in 2017
Investing News Network (press release) (registration) (blog) CRISPR gene-editing has been called the scientific breakthrough of the century … and sometimes, it feels like we’ve been hearing about it for just as long. Bacterial palindromic repeats—which are key to this technology—were first discovered in the … |
WJHL |
Former Titan Tim Shaw undergoes stem cell transplant in Israel …
WJHL WJHL-TV is the source for breaking local news, weather, and sports in the Tri-Cities. We ask the questions when you can’t with our investigative and community … |
WKRN.com |
Tim Shaw undergoes stem cell transplant in Israel
WKRN.com NASHVILLE, Tenn. (WKRN) – Former Titan Tim Shaw’s fight against ALS took him to Israel this week for a stem cell transplant. A month ago, Shaw went to Jerusalem where he had stem cells harvested from his body at the Hadassah Medical Center in Ein … |